Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Clinical pharmacology of old age syndromes.

Literature DB >> 12919174

Clinical pharmacology of old age syndromes.

C Broadhurst¹, K C M Wilson, M T Kinirons, A Wagg, J K Dhesi.

Abstract

Several syndromes occur in old age. They are often associated with increased mortality and in all there is a paucity of basic and clinical research. The recent developments in the clinical pharmacology of three common syndromes of old age (delirium, urinary incontinence, and falls) are discussed along with directions for future research.

Entities: Disease

Mesh：

Substances：
Vitamin D

Year: 2003 PMID： 12919174 PMCID： PMC1884351 DOI： 10.1046/j.0306-5251.2003.01877.x

Source DB: PubMed Journal: Br J Clin Pharmacol ISSN： 0306-5251 Impact factor: 4.335

158 in total

1. Serial incontinence assessment in elderly inpatient men.

Authors: P D O'Donnell; C Beck; R C Walls
Journal: J Rehabil Res Dev Date: 1990

2. Torsades de pointes secondary to intravenous haloperidol after coronary bypass grafting surgery.

Authors: L P Perrault; A Y Denault; M Carrier; R Cartier; S Bélisle
Journal: Can J Anaesth Date: 2000-03 Impact factor: 5.063

3. A comparison of emepronium bromide and flavoxate hydrochloride in the treatment of urinary incontinence.

Authors: S L Stanton
Journal: J Urol Date: 1973-11 Impact factor: 7.450

4. Cognitive impairment in medical inpatients. I: Screening for dementia--is history better than mental state?

Authors: D M Harwood; T Hope; R Jacoby
Journal: Age Ageing Date: 1997-01 Impact factor: 10.668

5. Identification of medications that cause cognitive impairment in older people: the case of oxybutynin chloride.

Authors: I R Katz; L P Sands; W Bilker; S DiFilippo; A Boyce; K D'Angelo
Journal: J Am Geriatr Soc Date: 1998-01 Impact factor: 5.562

6. Intravenous insulin-like growth factor-I (IGF-I) in moderate-to-severe head injury: a phase II safety and efficacy trial.

Authors: J Hatton; R P Rapp; K A Kudsk; R O Brown; M S Luer; J G Bukar; S A Chen; C J McClain; N Gesundheit; R J Dempsey; B Young
Journal: J Neurosurg Date: 1997-05 Impact factor: 5.115

Review 1. Delirium and its treatment.

Authors: Azizah Attard; Gopinath Ranjith; David Taylor
Journal: CNS Drugs Date: 2008 Impact factor: 5.749

1 in total

Clinical pharmacology of old age syndromes.

1. Serial incontinence assessment in elderly inpatient men.

2. Torsades de pointes secondary to intravenous haloperidol after coronary bypass grafting surgery.

3. A comparison of emepronium bromide and flavoxate hydrochloride in the treatment of urinary incontinence.

4. Cognitive impairment in medical inpatients. I: Screening for dementia--is history better than mental state?

5. Identification of medications that cause cognitive impairment in older people: the case of oxybutynin chloride.

6. Intravenous insulin-like growth factor-I (IGF-I) in moderate-to-severe head injury: a phase II safety and efficacy trial.

7. A novel approach to the prevention of postoperative delirium in the elderly after gastrointestinal surgery.

8. Cystometric response to propantheline in detrusor hyperreflexia: therapeutic implications.

9. 25-hydroxycholecalciferol stimulation of muscle metabolism.

10. Improvement of muscle strength after treatment for hyperparathyroidism.

Review 1. Delirium and its treatment.